Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TITAN: Ivermectin + Losartan for COVID-19 in Cancer Patients
NCT04447235Phase 2Terminated
- Sponsor
- Instituto do Câncer do Estado de São Paulo
- Start
- Jul 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ivermectin, losartan in coronavirus disease 2019 (COVID-19), sponsored by Instituto do Câncer do Estado de São Paulo. Started Jul 2020; status: terminated.
02
Drugs
ivermectinlosartan
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04447235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04447235.